Renuka V Iyer

7PUBLICATIONS
77CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Nov 24, 2025
A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers.

Mohammed M Alruwaili, Yanqi Guo, Justin Zonneville

|Dec 13, 2024
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers.

Rachna T Shroff, Gentry King, Sarah Colby

|Mar 19, 2024
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.

John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa

|Jan 13, 2022
Mutant PPM1D- and TP53-Driven Hematopoiesis Populates the Hematopoietic Compartment in Response to Peptide Receptor Radionuclide Therapy.

Abhay Singh, Nuria Mencia-Trinchant, Elizabeth A Griffiths

|Nov 16, 2020
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.

John D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa

Pageof 2

Frequent Collaborators

3 joint publications

R Katie Kelley

2 joint publications

John D Gordan

2 joint publications

Erin B Kennedy

2 joint publications

Ghassan K Abou-Alfa